Guinea-Bissau vs Mali: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Guinea-Bissau
65.0%
in 2025
Mali
68.0%
in 2025
Guinea-Bissau rank
8th
Mali rank
6th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Guinea-Bissau
- Mali
How they compare
Mali currently reports 68.0% against 65.0% in Guinea-Bissau, a difference of 3.0%.
Across all 10 years both countries report, Mali has been ahead every year.
Guinea-Bissau ranks 8th and Mali ranks 6th of 26 countries.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 44.8% | 44.8% | Mali |
| 2020s | 28.3% | 66.5% | 38.2% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Guinea-Bissau or Mali?
- Mali, at 68.0% against 65.0% in Guinea-Bissau as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Guinea-Bissau and Mali?
- 3.0%, with Mali ahead.
- How many years of comparable data are there for Guinea-Bissau and Mali?
- 10 years are reported by both, from 2016 to 2025.
- How do Guinea-Bissau and Mali rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Guinea-Bissau ranks 8th and Mali ranks 6th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.